Holding(s) in Company (6293A)
February 03 2011 - 5:21AM
UK Regulatory
TIDMHIK
RNS Number : 6293A
Hikma Pharmaceuticals Plc
03 February 2011
Notification of major interests in shares
LONDON, 3 February 2011 - Hikma Pharmaceuticals PLC ("Hikma")
(LSE: HIK) (DIFX: HIK), the fast growing multinational
pharmaceuticals group, announces as follows:
1 Identity of the issuer or the underlying Hikma Pharmaceuticals PLC
issuer of existing shares to which the
voting rights are attached
----------------------------------------- --------------------------
2 Reason for the notification
--------------------------------------------------------- ----
An acquisition or disposal of voting rights Yes
--------------------------------------------------------- ----
An acquisition or disposal of financial instruments No
which may result in the acquisition of shares already
issues to which voting rights are attached
--------------------------------------------------------- ----
An event changing the breakdown of voting rights No
--------------------------------------------------------- ----
Other (please specify): Compliance with the Transparency No
Directive
--------------------------------------------------------- ----
Full name of the person subject to the Sectoral Asset Management
3 notification obligation Inc. (SAM)
------------- --------------------------------------------------- ------------------------------------------
SAM acts as investment
advisors/sub investment
advisors to a large number
of institutional clients
globally. The actual shareholders
are those institutional
clients, some of whom
have delegated voting
4 Full name of shareholders authority to SAM.
------------- --------------------------------------------------- ------------------------------------------
Date of the Transaction (and date on
which the threshold crossed is reached
5 differently) 1 February 2011
------------- --------------------------------------------------- ------------------------------------------
6 Date on which the issuer notified 2 February 2011
------------- --------------------------------------------------- ------------------------------------------
7 Threshold that is crossed 3%
------------- --------------------------------------------------- ------------------------------------------
8 Notified details:
------------- --------------------------------------------------- ------------------------------------------
A. Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class type
of shares
(if possible Situation previous
using the to the triggering Resulting situation after the triggering
ISIN code) transaction transaction
--------------- ------------------------ -------------------------------------------------------------------
Number
Number of of voting Number of voting % of voting
shares rights Number of shares rights rights
------------- ---------- ------------ --------------------- ----------------------- -------------------
Direct Indirect Direct Indirect Direct Indirect
------------- ---------- ------------ ---------- --------- ------------ --------- -------- ---------
1.38%
2,587,193 2,677,293 with
Ordinary with SAM with SAM SAM
Shares (0.10 3,004,981 3,545,281 1.83%
GBP) with with with
GB00B0LCW083 5,592,174 clients 6,222,574 0 clients 0 clients 0%
--------------- ---------- ------------ ---------- --------- ------------ --------- -------- ---------
B. Qualifying Financial instruments
----------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------
Type of Expiration Exercise/Conversion Number of voting % of voting
financial Date Period/Date rights that may be rights
instrument acquired if the
instrument if
exercised/converted
----------- ----------- -------------------- -------------------- ------------
- - - - -
----------- ----------- -------------------- -------------------- ------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments
------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/Conversion Number of % of voting
financial Price Date Period/Date voting rights
instrument rights
instrument
refers to
----------- --------- ----------- -------------------- ----------- ------------------
Nominal Delta
----------- --------- ----------- -------------------- ----------- -------- --------
- - - - - - -
----------- --------- ----------- -------------------- ----------- -------- --------
Total A+B+C
---------------------------------------------
Number of Voting rights % of voting rights
------------------------ -------------------
SAM: 2,677,293 SAM: 1.38%
Clients: 3,545,281 Clients: 1.83%
------------------------ -------------------
9 Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable
----------------------------------------------------------------------
Sectoral Asset Management Inc (SAM) act as
investment advisors to clients who hold Hikma
shares. Some of those clients have delegated
their voting authority to SAM, while other SAM
clients have retained their voting authority.
The beneficial owners of the Hikma shares are
SAM clients.
----------------------------------------------------------------------
Proxy Voting
--------------------------------------------------------------------------
10 Name of the proxy holder Sectoral Asset Management Inc (SAM)
in respect of 1.38% of Hikma shares
--- ------------------------------ -------------------------------------
11 Number of voting rights proxy N/A
holder will cease to hold
--- ------------------------------ -------------------------------------
12 Date on which proxy holder N/A
will cease to hold voting
rights
--- ------------------------------ -------------------------------------
Notification using the total voting
13 Additional Information rights figure of 193,516,989
--- -------------------------- ------------------------------------
14 Contact name: Peter Speirs, Deputy Secretary
--- -------------------------- ------------------------------------
15 Contact telephone number: 020 7399 2772
--- -------------------------- ------------------------------------
- ENDS -
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics" based principally in the
Middle East and North Africa ("MENA") region, where it is a market
leader, the United States and Europe. In 2009, Hikma achieved
revenues of $637 million and profit attributable to shareholders of
$78 million. For news and other information, please visit
www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUOURRARAURAR
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
